https://www.selleckchem.com/pr....oducts/Pitavastatin-
Epigenetic modification of members of the Let-7 family such as miR-497, miR-486, and miR-223 is strongly associated with impaired glucose tolerance and CRC risk. Herein we review the pathophysiological and epidemiological evidence as well as potential underlying molecular mechanisms by which DM and hyperglycemia affect CRC risk. We also suggest potential roles of glucose modulation in CRC therapy and propose an agenda for future research and clinical practice. Intolerance of Uncertainty (IU) may be important for the
Beğen
Yorum Yap
Paylaş
